Physician Introduction on Irritable Bowel Syndrome (IBS)
Lin Chang, MD
More than 1 in every 4 adults in the United States, Canada, and the United Kingdom has one of the six functional bowel disorders. In this presentation, Dr. Lin chang will define irritable bowel syndrome (IBS), review the diagnostic approach based on the Rome Criteria, review treatment options for IBS with diarrhea (IBS-D) and IBS with constipation (IBS-C), and much more.
About Dr. Chang
Lin Chang, MD
Vice Chief, Vatche and Tamar Manoukian Division of Digestive Diseases
Program Director, UCLA GI Fellowship Program
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
Professor of Medicine
David Geffen School of Medicine at UCLA
Dr. Chang is a Professor of Medicine at the David Geffen School of Medicine at UCLA. She is Vice-Chief of the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA, Co-Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience, and Program Director of the UCLA Gastroenterology Fellowship Program. Dr. Chang’s clinical expertise is in disorders of gut-brain interactions which include irritable bowel syndrome (IBS), chronic constipation and functional dyspepsia. Her research is focused on the pathophysiology of IBS related to stress, sex differences, genetic and epigenetic factors, neuroendocrine alterations, and gut microbiome and the treatment of IBS. Dr. Chang is a recipient of the Janssen Award in Gastroenterology for Basic or Clinical Research, AGA Distinguished Clinician Award, and AGA Distinguished Educator Award. Active in professional organizations, she is a member of the Rome Foundation Board of Directors and previously served as Clinical Research Councilor of the American Gastroenterological Association (AGA) Governing Board and president of the American Neurogastroenterology and Motility Society (ANMS).